GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 159 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $1,182,000 | -52.2% | 23,126 | -25.6% | 0.37% | -32.5% |
Q4 2019 | $2,471,000 | +3.7% | 31,085 | -37.0% | 0.54% | +37.0% |
Q1 2018 | $2,382,000 | +33.1% | 49,311 | +8.5% | 0.40% | +24.1% |
Q4 2017 | $1,789,000 | -16.4% | 45,460 | -34.1% | 0.32% | +12.3% |
Q3 2017 | $2,141,000 | -12.8% | 68,961 | -23.2% | 0.28% | -29.8% |
Q2 2017 | $2,455,000 | -30.8% | 89,750 | -6.7% | 0.41% | -27.4% |
Q1 2017 | $3,546,000 | – | 96,225 | – | 0.56% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
Grace Capital | 124,749 | $6,878,000 | 5.33% |
Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |